BRPI0814318A2 - Forma cristalina, composição, e, uso de uma quantidade terapeuticamente eficaz de uma composição - Google Patents

Forma cristalina, composição, e, uso de uma quantidade terapeuticamente eficaz de uma composição

Info

Publication number
BRPI0814318A2
BRPI0814318A2 BRPI0814318-8A2A BRPI0814318A BRPI0814318A2 BR PI0814318 A2 BRPI0814318 A2 BR PI0814318A2 BR PI0814318 A BRPI0814318 A BR PI0814318A BR PI0814318 A2 BRPI0814318 A2 BR PI0814318A2
Authority
BR
Brazil
Prior art keywords
composition
crystalline form
therapeutically efficient
efficient quantity
therapeutically
Prior art date
Application number
BRPI0814318-8A2A
Other languages
English (en)
Inventor
Fritz Blatter
Meinrad Brenner
Guixian Hu
Timo Rager
Ralf Warrass
Original Assignee
Intervet Int Bv
Microbial Chem Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv, Microbial Chem Res Found filed Critical Intervet Int Bv
Publication of BRPI0814318A2 publication Critical patent/BRPI0814318A2/pt
Publication of BRPI0814318B1 publication Critical patent/BRPI0814318B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
BRPI0814318-8A 2007-07-26 2008-07-25 Forma cristalina, composição, uso de uma quantidade terapeuticamente eficaz de uma composição, e, composição farmacêutica BRPI0814318B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07113244.3 2007-07-26
EP07113244A EP2019112A1 (en) 2007-07-26 2007-07-26 Macrolide solid-state forms
PCT/EP2008/059775 WO2009013351A2 (en) 2007-07-26 2008-07-25 Macrolide solid-state forms

Publications (2)

Publication Number Publication Date
BRPI0814318A2 true BRPI0814318A2 (pt) 2015-01-06
BRPI0814318B1 BRPI0814318B1 (pt) 2021-04-06

Family

ID=39467287

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0814318-8A BRPI0814318B1 (pt) 2007-07-26 2008-07-25 Forma cristalina, composição, uso de uma quantidade terapeuticamente eficaz de uma composição, e, composição farmacêutica

Country Status (13)

Country Link
EP (3) EP2019112A1 (pt)
JP (7) JP5925989B2 (pt)
KR (2) KR20160003899A (pt)
CN (5) CN101778858B (pt)
AU (1) AU2008278969B8 (pt)
BR (1) BRPI0814318B1 (pt)
CA (1) CA2693801C (pt)
ES (2) ES2805534T3 (pt)
HU (1) HUE031449T2 (pt)
RU (1) RU2476438C2 (pt)
TW (1) TWI427083B (pt)
WO (1) WO2009013351A2 (pt)
ZA (1) ZA201000188B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2019112A1 (en) * 2007-07-26 2009-01-28 Intervet International BV Macrolide solid-state forms
KR101456308B1 (ko) 2006-07-28 2014-11-03 인터벳 인터내셔널 비.브이. 마크롤라이드 합성 방법
HUE036856T2 (hu) 2011-11-25 2018-08-28 Bayer Ip Gmbh Antibakteriális tilozinszármazékok és eljárás elõállításukra
CN102816196A (zh) * 2012-09-10 2012-12-12 河北远征药业有限公司 泰地罗新半抗原、人工抗原及其制备方法
MX361808B (es) * 2013-05-23 2018-12-14 Bayer Animal Health Gmbh Derivados de tilosina y metodo para su preparacion.
CN103554203A (zh) * 2013-08-17 2014-02-05 齐鲁动物保健品有限公司 一种泰地罗新无定形晶及其制备方法
CN104478974B (zh) * 2014-11-28 2016-08-17 武汉回盛生物科技有限公司 一种20，23-二哌啶基-5-o-碳霉胺糖基-泰乐内酯的合成方法
CN104447919B (zh) * 2014-11-28 2017-03-08 武汉回盛生物科技股份有限公司 一种20，23‑二哌啶基‑5‑o‑碳霉胺糖基‑泰乐内酯原料药的精制方法
CN104497082B (zh) * 2015-01-13 2017-12-12 中国兽医药品监察所 一种泰地罗新的合成方法
CN104774223A (zh) * 2015-03-26 2015-07-15 宁夏泰瑞制药股份有限公司 一种利用泰乐菌素碱生产泰地罗新的方法
CN105254693B (zh) * 2015-11-13 2017-12-22 周金华 一种泰地罗新的合成方法
CN106008629B (zh) * 2016-06-02 2019-11-22 天津大学 泰地罗新1,4-二氧六环溶剂化合物及制备方法
CN106046084B (zh) * 2016-06-02 2019-08-09 天津大学 泰地罗新丙酮溶剂化合物及制备方法
CN106083958B (zh) * 2016-06-02 2019-07-23 天津大学 泰地罗新环己烷溶剂化合物及制备方法
CN109721633A (zh) * 2017-10-31 2019-05-07 齐鲁晟华制药有限公司 一种泰地罗新晶型a及其制备方法
CN111349130A (zh) * 2018-12-21 2020-06-30 齐鲁动物保健品有限公司 一种泰地罗新晶型b及其制备方法
WO2022117701A1 (en) 2020-12-03 2022-06-09 Intervet International B.V. A method of treating foot rot
CN114213484A (zh) * 2021-12-21 2022-03-22 河北远征药业有限公司 一种泰地罗新1，2-丙二醇溶剂化合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL33732A (en) * 1969-02-06 1973-05-31 Meiji Seika Kaisha The new antibiotics sf-837,sf-837-a2,sf-837-a3 and sf-837-a4 and their production
US4820695A (en) 1982-09-13 1989-04-11 Eli Lilly And Company C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics
IL69666A (en) 1982-09-13 1987-10-20 Lilly Co Eli 20-amino-20-deoxo-5-o-mycaminosyl-23-o-mycinosyltylonolide derivatives,their preparation and veterinary antibiotic use
SI8311553A8 (en) * 1983-07-18 1995-06-30 Pliva Pharm & Chem Works Process for preparing 7,16-dioxa-2-aza-10-0-cladynosil-12-0-desosaminyl-4,5-dihydroxy-6- ethyl-3,5,9,11,13,15-hexamethylbicyclo (11.2.1.) hexadeca-1(2)-ene-8-ones
US4921947A (en) * 1986-03-31 1990-05-01 Eli Lilly And Company Process for preparing macrolide derivatives
US4920103A (en) 1986-09-29 1990-04-24 Eli Lilly And Company Modifications of mycinose and 3-O-demethylmycinose in tylosin-type macrolides
ES2213597T3 (es) * 1999-08-30 2004-09-01 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Antibioticos macrolidos y tratamiento de la pasteurelosis.
EP1638549A4 (en) * 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
AU2003269473A1 (en) * 2003-08-26 2005-03-10 Biocon Limited A process for the recovery of substantially pure tricyclic macrolide
JP2007527434A (ja) * 2005-01-05 2007-09-27 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ 非晶質タクロリマス及びその調製
KR101456308B1 (ko) * 2006-07-28 2014-11-03 인터벳 인터내셔널 비.브이. 마크롤라이드 합성 방법
EP2019112A1 (en) * 2007-07-26 2009-01-28 Intervet International BV Macrolide solid-state forms
CN101506220B (zh) * 2006-07-28 2012-10-17 英特威国际有限公司 大环内酯合成方法

Also Published As

Publication number Publication date
BRPI0814318B1 (pt) 2021-04-06
RU2476438C2 (ru) 2013-02-27
JP2020172516A (ja) 2020-10-22
CN103360447B (zh) 2016-04-06
TW200918547A (en) 2009-05-01
CN103360446B (zh) 2016-04-06
JP2020172517A (ja) 2020-10-22
WO2009013351A2 (en) 2009-01-29
CN101778858A (zh) 2010-07-14
CA2693801C (en) 2018-08-14
KR20160003899A (ko) 2016-01-11
EP2181117B1 (en) 2016-11-09
KR102508115B1 (ko) 2023-03-08
ES2805534T3 (es) 2021-02-12
CN103360446A (zh) 2013-10-23
WO2009013351A3 (en) 2009-04-02
CN103360445B (zh) 2016-05-18
AU2008278969A1 (en) 2009-01-29
EP3170833A1 (en) 2017-05-24
HUE031449T2 (en) 2017-07-28
CN103467548A (zh) 2013-12-25
TWI427083B (zh) 2014-02-21
EP2019112A1 (en) 2009-01-28
JP2018109020A (ja) 2018-07-12
EP3170833B1 (en) 2020-05-20
ES2608978T3 (es) 2017-04-17
JP2010534635A (ja) 2010-11-11
JP2014088394A (ja) 2014-05-15
AU2008278969B8 (en) 2012-03-15
KR20100044864A (ko) 2010-04-30
RU2010107057A (ru) 2011-09-10
JP5925989B2 (ja) 2016-05-25
EP2181117A2 (en) 2010-05-05
CN103360445A (zh) 2013-10-23
JP2018104449A (ja) 2018-07-05
ZA201000188B (en) 2010-09-29
CN101778858B (zh) 2013-12-04
JP2016147858A (ja) 2016-08-18
CA2693801A1 (en) 2009-01-29
CN103360447A (zh) 2013-10-23
JP6343624B2 (ja) 2018-06-13
AU2008278969B2 (en) 2011-11-17

Similar Documents

Publication Publication Date Title
BRPI0814318A2 (pt) Forma cristalina, composição, e, uso de uma quantidade terapeuticamente eficaz de uma composição
BRPI0821165A2 (pt) Uso de uma composição
LTPA2018005I1 (lt) Farmacinė kompozicija
BRPI0813770A2 (pt) Composição, e, uso de uma composição
BRPI0822398B8 (pt) forma sólida cristalina e composição farmacêutica que a compreende
PL2121537T3 (pl) Nowe kompozycje betonowe
BRPI0813775A2 (pt) Composição
DK1984009T3 (da) Farmaceutiske sammensætninger med forbedret stabilitet
BRPI0716325A2 (pt) Composição antimicrobianas
ATE528048T1 (de) Schweisshemmende/desodorierende zusammensetzung
BRPI0721651A2 (pt) Composição farmacêutica
FR2899479B1 (fr) Composition cicatrisante
BRPI1013421A2 (pt) composição parasticida tópica, e, uso de uma composição
BRPI0812592A2 (pt) Composição assada
BRPI0810557A2 (pt) composição
BRPI0914793A2 (pt) Composição, e, uso de uma composição
DK2120884T3 (da) Farmaceutisk sammensætning
BRPI0811274A2 (pt) Composição
BRPI0906253A2 (pt) Composição de dentifrício, e, uso de uma composição
DK2246477T3 (da) Spunspæl med dobbelt t-form
DK2346679T3 (da) Forbedrede kompositmaterialer
BRPI0811002A2 (pt) Composição biofertilizante
ZA201000667B (en) Anti-inflammatory composition
EP2001817A4 (en) LIGHT CONCRETE COMPOSITIONS
BRPI0820960A2 (pt) composição

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/04/2021, OBSERVADAS AS CONDICOES LEGAIS.